SHL Telemedicine Ltd. (SWX:SHLTN)
Switzerland · Delayed Price · Currency is CHF 1.060
-0.010 (-0.93%)
Sep 11, 2026, 5:30 PM CET
SHL Telemedicine Market Cap
SHL Telemedicine has a market cap or net worth of 39.28 million as of September 11, 2026. Its market cap has increased by 82.94% in one year.
Market Cap
39.28M
Enterprise Value
32.33M
Revenue
50.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.06
ChartMarket Cap Chart
Since November 14, 2000, SHL Telemedicine's market cap has decreased from 229.59M to 39.28M, a decrease of -82.89%. That is a compound annual growth rate of -6.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 39.28M | -10.17% |
| Dec 30, 2025 | 43.73M | 2.61% |
| Dec 30, 2024 | 42.62M | -62.59% |
| Dec 29, 2023 | 113.92M | -47.37% |
| Dec 30, 2022 | 216.45M | -21.67% |
| Dec 30, 2021 | 276.35M | 121.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 276.04B |
| Novartis AG | 213.15B |
| Lonza Group AG | 37.10B |
| Galderma Group AG | 35.84B |
| Newron Pharmaceuticals | 237.19M |
| Ascom Holding AG | 172.83M |
| BioVersys AG | 155.43M |
| Molecular Partners AG | 129.85M |